Our mission is to make advanced ophthalmic imaging diagnostics accessible to populations unable to access conventional tabletop clinical imaging
Theia Imaging is developing easy-to-use, compact, portable eye imaging systems for use in infants, children and those unable to cooperate for conventional tabletop clinical eye diagnostics.
Our mission is to bring access to advanced ophthalmic imaging diagnostics to populations unable to access conventional tabletop clinical imaging. This spans the range of human eye disease from: retinopathy of prematurity to diabetic retinopathy, glaucoma, age-related macular degeneration, as well as inherited retinal diseases.
Beyond retinal diagnostics, our advanced imaging technologies also provide non-invasive access to neurological information. The eye is often referred to as the “window to the brain”, as retina and optic nerve head are direct extensions of brain tissue. Thus, the microanatomy and microvascular flow within the eye can provide valuable information about brain development and brain disease.
Introducing the T1 Investigational System
- Faster: Leveraging next-generation swept source technology, the T1’s 300kHz A-scan rate provides an order of magnitude reduction in image acquisition time, simplifying image capture and enabling dense volume sampling, even with squirming subjects.
- Lighter: At under 350 grams (12 oz), the T1 imaging probe weighs in at less than a quarter of the weight of competitive devices, eliminating hand fatigue and providing an extra factor of safety for imaging delicate subjects.
- Easier: The T1’s revolutionary ergonomic design and an integrated pupil camera with NIR illumination simplify image alignment without a bright, uncomfortable stimulus.
Example images from the T1 device:
peripheral scan (A), macular scan (B), en face retina view (C) and pupil camera view (D).
Dr. Toth demonstrating the T1 at ARVO 2022. With superior image quality, speed, ergonomics and portability, the T1 allows you to take the best OCT device with you, anywhere.
Light source 1060nm Swept Source Laser
Image acquisition speed Up to 500 frames/second
Volume acquisition speed 4 volumes/second
Optical Safety Compliant with ANSI z80.36-2021 (Group 1)
Axial resolution (in tissue) 6 microns
Imaging depth (in tissue) 3 mm (customizable up to 6mm)
Lateral field of view 44 degrees** (13mm nominal)
Lateral resolution 11 microns
** The T1’s 44 degree FOV is measured using the “visual angle” definition provided in ISO 10940 and ISO 16971, and is equivalent to a 70 degree FOV using “internal angle” definitions
Cart Ultra mobile cart with 9 foot (2.7m) tether length
Cart footprint 21” wide x 19” deep x 58” height (height adjustable)
Scan head weight 350 g
Scan head footprint 6” x 6” x 2” (excluding tether)
The T1 SSOCT device has not been cleared by the FDA and is currently available for investigational use with appropriate IRB and/or IACUC approvals.
Theia Imaging was formed in the Spring of 2020 by three founders with pioneering expertise in translational research, pediatric eye care and ophthalmic diagnostics.
Hafeez Dhalla, PhD, MBA
Founder & Chief Executive Officer
- PhD in Biomedical Engineering, Duke University
- Postdoctoral Fellowship, Massachusetts Institute of Technology
- MBA, Quantic School of Business and Technology
Dr. Dhalla’s expertise spans the academic, research and commercial worlds of biomedical optics and medical imaging. Before co-founding Theia Imaging, he lead the development of multiple FDA-cleared ophthalmic devices as an engineer and consultant. Dr. Dhalla also holds an academic appointment in Biomedical Engineering at Duke University. His commercial and academic research has lead to 11 issued and pending patents.
Christian Viehland, PhD
Founder & Chief Technical Officer
- BS in Electrical and Electronics Engineering, and in Biomedical/Medical Engineering, University of Virginia
- PhD in Biomedical Engineering, Duke University
- Entrepreneurial Postdoctoral Fellow, Biomedical Engineering, Duke University
Dr. Viehland is an experienced optical engineering who has developed numerous ophthalmic imaging systems and has collaborated extensively with Dr. Toth and Dr. Dhalla on the translation of these systems for pediatric applications.
Cynthia A Toth, MD
Founder & Chief Medical Officer
- MD from Drexel University (Medical College of Pennsylvania)
- Ophthalmology Residency, Geisinger Medical Center
- Fellowship in Diseases and Surgery of the Retina, University of California at Davis
Dr. Toth is an internationally recognized pediatric ophthalmologist who has worked in OCT translational research since 1992. She is the Editor of the “Handbook of Pediatric Retinal OCT and the Eye-Brain Connection” and has 20 issued patents for microsurgical devices and ophthalmic imaging technologies.
Theia Imaging’s Financial Conflict of Interest (FCOI) Policy is available here. Please address any concerns regarding this policy to fcoi [at] theiaimaging [dot] com